FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy

Abstract Our aim was to analyse whether biomarkers extracted from baseline 18F-FDG PET before anti-PD1 treatment contribute to prognostic survival information for early risk stratification in metastatic melanoma. Fifty-six patients, without prior systemic treatment, BRAF wild type, explored using 18...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: A. Flaus, V. Habouzit, N. De Leiris, J. P. Vuillez, M. T. Leccia, J. L. Perrot, N. Prevot, F. Cachin
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/f670e00483354b05be876dfe62c9c6da
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!